Independent of tumor type and non‐invasive or minimally‐invasive feature, current physical
treatments including ultrasound therapy, microwave ablation (MWA), and radiofrequency …

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death worldwide.
Local ablation, such as radiofrequency ablation, microwave ablation, cryoablation and …

Conclusions: Our study sheds light on the pivotal role of METTL1 in modulating an
immunosuppressive microenvironment and demonstrated that interrupting METTL1‐TGF‐β2 …

Immunotherapy has remarkably revolutionized the management of advanced HCC and
prompted clinical trials, with therapeutic agents being used to selectively target immune cells …

Cases of hepatocellular carcinoma (HCC) are rapidly rising. This is particularly the case in
the Western world, as a result of increasing rates of chronic liver disease, secondary to …

Simple Summary Immunotherapy is emerging as an improved systemic treatment for select
patients with advanced unresectable hepatocellular carcinoma. An objective response is …

As a safe and minimal-invasive modality, thermal therapy has become an effective treatment
in cancer treatment. Other than killing the tumor cells or destroying the tumor entirely, the …

Hepatocellular carcinoma (HCC) is a highly aggressive disease that is usually diagnosed at
an advanced stage. Advanced HCC has limited treatment options and often has a poor …

Introduction Combination of immune-checkpoint inhibitor (ICI) and vascular endothelial
growth factor (VEGF) antagonist has become the first line systemic treatment for advanced …

Among primary liver cancers, hepatocellular carcinoma is the most common pathological
type. Its onset is insidious, and most patients have no obvious discomfort in the early stage …